Bonesupport Holding AB (publ) (BONEX.ST)

SEK 382.8

(2.03%)

EBITDA Summary of Bonesupport Holding AB (publ)

Bonesupport Holding AB (publ)'s latest annual EBITDA in 2023 was 28.93 Million SEK , up 159.38% from previous year.
Bonesupport Holding AB (publ)'s latest quarterly EBITDA in 2024 Q2 was 31.61 Million SEK , down -8.25% from previous quarter.
Bonesupport Holding AB (publ) reported an annual EBITDA of -54.34 Million SEK in 2022, up 25.3% from previous year.
Bonesupport Holding AB (publ) reported an annual EBITDA of -72.39 Million SEK in 2021, up 19.76% from previous year.
Bonesupport Holding AB (publ) reported a quarterly EBITDA of 34.46 Million SEK for 2024 Q1, up 1518.41% from previous quarter.
Bonesupport Holding AB (publ) reported a quarterly EBITDA of 31.61 Million SEK for 2024 Q2, down -8.25% from previous quarter.

Annual EBITDA Chart of Bonesupport Holding AB (publ) (2023 - 2014)

Historical Annual EBITDA of Bonesupport Holding AB (publ) (2023 - 2014)

Year	EBITDA	EBITDA Growth
2023	28.93 Million SEK	159.38%
2022	-54.34 Million SEK	25.3%
2021	-72.39 Million SEK	19.76%
2020	-90.91 Million SEK	39.68%
2019	-150.87 Million SEK	12.73%
2018	-172.97 Million SEK	-56.97%
2017	-101.55 Million SEK	-14.4%
2016	-92.24 Million SEK	-92.38%
2015	-49.7 Million SEK	-14.89%
2014	-43.34 Million SEK	0.0%

Year	EBITDA	EBITDA Growth
2024 Q3	42.83 Million SEK	35.49%
2024 Q1	34.46 Million SEK	1518.41%
2024 Q2	31.61 Million SEK	-8.25%
2023 Q2	7.82 Million SEK	216.84%
2023 Q4	7.21 Million SEK	-57.01%
2023 FY	- SEK	159.38%
2023 Q1	2.47 Million SEK	117.45%
2023 Q3	16.78 Million SEK	114.33%
2022 Q3	-12.29 Million SEK	5.28%
2022 Q4	-14.16 Million SEK	-15.13%
2022 FY	- SEK	25.3%
2022 Q2	-12.98 Million SEK	12.83%
2022 Q1	-14.89 Million SEK	16.31%
2021 Q2	-24.9 Million SEK	-41.6%
2021 Q4	-17.8 Million SEK	-47.2%
2021 Q1	-17.59 Million SEK	24.63%
2021 FY	- SEK	19.76%
2021 Q3	-12.09 Million SEK	51.45%
2020 Q1	-29.2 Million SEK	24.14%
2020 FY	- SEK	39.68%
2020 Q4	-23.33 Million SEK	-31.9%
2020 Q3	-17.69 Million SEK	24.62%
2020 Q2	-23.47 Million SEK	19.63%
2019 Q1	-38.99 Million SEK	14.73%
2019 FY	- SEK	12.73%
2019 Q4	-38.5 Million SEK	-17.78%
2019 Q3	-32.68 Million SEK	31.64%
2019 Q2	-47.82 Million SEK	-22.63%
2018 Q4	-45.73 Million SEK	19.93%
2018 FY	- SEK	-56.97%
2018 Q1	-33.13 Million SEK	26.32%
2018 Q2	-37.82 Million SEK	-14.16%
2018 Q3	-57.11 Million SEK	-51.02%
2017 Q3	-20.11 Million SEK	-9.55%
2017 Q1	-27.43 Million SEK	26.99%
2017 Q2	-18.36 Million SEK	33.07%
2017 Q4	-44.96 Million SEK	-123.56%
2017 FY	- SEK	-14.4%
2016 Q2	-20.82 Million SEK	-52.46%
2016 FY	- SEK	-92.38%
2016 Q4	-37.57 Million SEK	-45.29%
2016 Q3	-25.86 Million SEK	-24.18%
2016 Q1	-13.66 Million SEK	0.0%
2015 FY	- SEK	-14.89%
2014 FY	- SEK	0.0%

Peer EBITDA Comparison of Bonesupport Holding AB (publ)

Name	EBITDA	EBITDA Difference
AddLife AB (publ)	1.54 Billion SEK	98.128%
Biotage AB (publ)	432 Million SEK	93.302%
Doxa AB (publ)	296 Million SEK	90.224%
Elekta AB (publ)	3.29 Billion SEK	99.121%
iZafe Group AB (publ)	-15.61 Million SEK	285.292%
Ortivus AB (publ)	-14.92 Million SEK	293.87%
Ortivus AB (publ)	-14.92 Million SEK	293.87%
Q-linea AB (publ)	-210.98 Million SEK	113.715%
S2Medical AB (publ)	-13.52 Million SEK	313.887%
Synsam AB (publ)	1.71 Billion SEK	98.309%